Altaris completes acquisition of Sharecare
Sharecare, a health tech company, has been acquired by Altaris for $1.43 per share in cash. The transaction, announced on June 21, 2024, received stockholder approval on October 17, 2024. As a result, Sharecare's common stock has ceased trading on the Nasdaq stock market.
Jeff Arnold, Sharecare's founder and executive chairman, stated that the acquisition delivers significant value to stockholders and provides support from an experienced, growth-oriented investor. Brent Layton, CEO of Sharecare, emphasized that the take-private transaction offers operational flexibility for profitable growth and continued innovation.
Arnold and certain affiliates of Claritas Capital will remain significant shareholders. Sharecare's leadership team will stay in place, maintaining its Atlanta headquarters and operating under its existing brand as a standalone company under Altaris' ownership.
Sharecare, un'azienda di tecnologia sanitaria, è stata acquisita da Altaris per 1,43 dollari per azione in contanti. La transazione, annunciata il 21 giugno 2024, ha ricevuto l'approvazione degli azionisti il 17 ottobre 2024. Di conseguenza, il titolo comune di Sharecare ha smesso di essere scambiato sul mercato azionario Nasdaq.
Jeff Arnold, fondatore e presidente esecutivo di Sharecare, ha dichiarato che l'acquisizione offre un valore significante agli azionisti e fornisce supporto da parte di un investitore esperto e orientato alla crescita. Brent Layton, CEO di Sharecare, ha sottolineato che la transazione di take-private offre flessibilità operativa per una crescita profittevole e un'innovazione continua.
Arnold e alcuni soci di Claritas Capital rimarranno azionisti significativi. Il team dirigenziale di Sharecare rimarrà in carica, mantenendo la propria sede ad Atlanta e operando con il brand esistente come azienda indipendente sotto la proprietà di Altaris.
Sharecare, una empresa de tecnología de salud, ha sido adquirida por Altaris por $1.43 por acción en efectivo. La transacción, anunciada el 21 de junio de 2024, recibió la aprobación de los accionistas el 17 de octubre de 2024. Como resultado, las acciones de Sharecare han dejado de cotizar en el mercado de valores Nasdaq.
Jeff Arnold, fundador y presidente ejecutivo de Sharecare, declaró que la adquisición aporta un valor significativo a los accionistas y brinda apoyo de un inversor experimentado y orientado al crecimiento. Brent Layton, CEO de Sharecare, enfatizó que la transacción de privatización ofrece flexibilidad operativa para un crecimiento rentable y una continua innovación.
Arnold y ciertos afiliados de Claritas Capital seguirán siendo accionistas significativos. El equipo de liderazgo de Sharecare se mantendrá en su lugar, conservando su sede en Atlanta y operando bajo su marca existente como una empresa independiente bajo la propiedad de Altaris.
Sharecare는 Altaris에 인수되었습니다 주당 1.43달러 현금으로 거래되었습니다. 이번 거래는 2024년 6월 21일에 발표되었으며, 2024년 10월 17일에 주주 승인도 받았습니다. 결과적으로 Sharecare의 보통주 거래는 나스닥 주식 시장에서 중단되었습니다.
Sharecare의 창립자이자 회장인 Jeff Arnold는 이번 인수가 주주들에게 상당한 가치를 제공하고 성장 지향적인 경험 많은 투자자로부터 지원을 받는다고 밝혔습니다. Sharecare의 CEO인 Brent Layton은 이번 사적 투자 거래가 수익성 있는 성장과 지속적인 혁신을 위한 운영 유연성을 제공한다고 강조했습니다.
Arnold와 Claritas Capital의 특정 제휴자는 여전히 주요 주주로 남을 것입니다. Sharecare의 경영진은 자리를 유지하며 애틀랜타 본사를 유지하고 Altaris 소속의 독립 기업으로 기존 브랜드 하에 운영할 것입니다.
Sharecare, une entreprise de technologie de la santé, a été acquise par Altaris pour 1,43 $ par action en espèces. La transaction, annoncée le 21 juin 2024, a reçu l'approbation des actionnaires le 17 octobre 2024. En conséquence, l'action ordinaire de Sharecare a cessé d'être cotée sur le marché boursier Nasdaq.
Jeff Arnold, fondateur et président exécutif de Sharecare, a déclaré que cette acquisition apporte une valeur significative aux actionnaires et fournit un soutien d'un investisseur expérimenté et axé sur la croissance. Brent Layton, PDG de Sharecare, a souligné que cette opération de privatisation offre une flexibilité opérationnelle pour une croissance rentable et une innovation continue.
Arnold et certains affiliés de Claritas Capital resteront des actionnaires significatifs. L'équipe de direction de Sharecare restera en place, maintenant son siège à Atlanta et opérant sous sa marque existante en tant qu'entreprise indépendante sous la propriété d'Altaris.
Sharecare, ein Unternehmen im Bereich Gesundheitstechnologie, wurde für 1,43 USD pro Aktie in bar von Altaris übernommen. Die Transaktion, die am 21. Juni 2024 angekündigt wurde, erhielt am 17. Oktober 2024 die Zustimmung der Aktionäre. Infolgedessen wird die Stammaktie von Sharecare nicht mehr an der Nasdaq-Börse gehandelt.
Jeff Arnold, Gründer und Vorstandsvorsitzender von Sharecare, erklärte, dass die Übernahme den Aktionären einen erheblichen Wert bietet und Unterstützung von einem erfahrenen, wachstumsorientierten Investor bereitstellt. Brent Layton, CEO von Sharecare, betonte, dass die Übernahme Flexibilität für rentables Wachstum und fortwährende Innovationen bietet.
Arnold und bestimmte Beteiligte von Claritas Capital werden weiterhin bedeutende Aktionäre bleiben. Das Führungsteam von Sharecare bleibt im Amt, behält den Hauptsitz in Atlanta und operiert unter der bestehenden Marke als eigenständiges Unternehmen im Besitz von Altaris.
- Acquisition price of $1.43 per share in cash provides immediate value to shareholders
- Support from Altaris, an experienced healthcare-focused investment firm
- Increased operational flexibility for focusing on profitable growth
- Retention of existing leadership team and brand identity
- Delisting from Nasdaq stock market, potentially reducing liquidity for remaining shareholders
- Transition from public to private company may limit transparency for stakeholders
Insights
The acquisition of Sharecare by Altaris for
- The transaction removes Sharecare from public market pressures, potentially allowing for more long-term strategic focus.
- Altaris' expertise in healthcare investments could provide valuable resources and industry connections for Sharecare's growth.
- The retention of Sharecare's leadership team and continued involvement of founder Jeff Arnold suggests operational continuity.
- The deal may enable Sharecare to pursue more aggressive growth strategies without quarterly earnings scrutiny.
While the
Sharecare's acquisition by Altaris represents a strategic shift in the digital health sector. The company's comprehensive platform, which includes benefits navigation, digital therapeutics and wellness programs, addresses critical needs in the healthcare ecosystem. Key technological implications include:
- Potential for accelerated innovation in personalized and value-based care solutions
- Enhanced ability to integrate AI and data analytics for improved health outcomes
- Opportunity to expand Sharecare's reach across employer, health plan and provider channels
The private ownership structure may allow Sharecare to make bolder technological investments and pursue more disruptive strategies in the competitive health tech market. However, the company will need to balance innovation with the operational efficiency demands of private equity ownership to maximize its potential under Altaris.
ATLANTA and NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced the completion of its acquisition by Altaris, LLC (collectively with its managed funds, “Altaris”), an investment firm exclusively focused on the healthcare industry, for
“Sharecare’s Board of Directors and shareholders determined that this transaction with Altaris was in the best interests of our company and our clients, and delivered significant, immediate, and certain value to our stockholders,” said Jeff Arnold, Sharecare’s founder and executive chairman of the Board of Directors. “With Altaris, Sharecare has gained the support of an experienced, growth-oriented investor that believes in the company’s vision, strategic growth plan, and management team, and shares a commitment to maximizing the value of Sharecare’s full potential across our three channels.”
Through Sharecare’s flexible, data-driven platform and comprehensive solutions – including benefits navigation, evidence-based coaching and digital therapeutics, wellness programs, home care resources, health information management, and more – the company helps people easily and efficiently manage their healthcare and improve their well-being. Across its three business channels, Sharecare enables employers, commercial and government health plans, and managed care organizations, as well as providers and life sciences companies to drive personalized and value-based care at scale.
“This take-private transaction provides Sharecare with the operational flexibility to focus on profitable growth and positions us to help our customers better address their and their populations’ needs through continued innovation,” said Brent Layton, CEO of Sharecare. “We are enthusiastic about this next phase of Sharecare’s evolution, and our team is laser focused on continuing to deliver exceptional service to our existing and future clients, including developing and deploying best-in-class solutions that make healthcare more personalized, accessible, and affordable for everyone.”
As part of the transaction, Arnold rolled over the majority of his equity holdings and certain affiliates of Claritas Capital, LLC (“Claritas”) rolled over all of their equity holdings. Arnold and Claritas will continue to be significant shareholders in Sharecare going forward.
Sharecare’s leadership team will remain in place and will continue to be focused on delivering measurable results for customers and driving sustainable growth for the company. Sharecare will maintain its headquarters in Atlanta and continue to operate under its existing brand as a standalone company under Altaris’ ownership.
Advisors
Houlihan Lokey and MTS Health Partners acted as financial advisors to the Special Committee, and Wachtell, Lipton, Rosen & Katz served as legal advisor to the Special Committee. Kirkland & Ellis LLP acted as legal advisor to Altaris. King & Spalding LLC acted as legal advisor to Jeff Arnold. RBC Capital Markets, LLC acted as financial advisor to Claritas, and Ropes & Gray LLP served as legal advisor to Claritas.
About Sharecare
Sharecare is a digital healthcare company that delivers software and tech-enabled services to stakeholders across the healthcare ecosystem to help improve care quality, drive better outcomes, and lower costs. Through its data-driven AI insights, evidence-based resources, and comprehensive platform – including benefits navigation, care management, home care resources, health information management, and more – Sharecare helps people easily and efficiently manage their healthcare and improve their well-being. Across its three business channels, Sharecare enables health plan sponsors, health systems and physician practices, and leading pharmaceutical brands to drive personalized and value-based care at scale. To learn more, visit www.sharecare.com.
About Altaris
Altaris is an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry. Since inception in 2003, Altaris has invested in more than 50 companies across a range of healthcare subsectors, with a consistent goal of delivering value to the healthcare system and generating attractive financial returns for investors. Altaris is headquartered in New York City and manages
Contacts:
Investor relations: investors@sharecare.com
Media relations: Jen Martin Hall, jen@sharecare.com
FAQ
What is the acquisition price for Sharecare (SHCR)?
When was the Sharecare (SHCR) acquisition by Altaris completed?
Will Sharecare (SHCR) continue to trade on the Nasdaq after the Altaris acquisition?
Who will lead Sharecare (SHCR) following the Altaris acquisition?
